Talk:Haridra: Difference between revisions
Jump to navigation
Jump to search
Dridhabala (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Curcuma longa L. | {{#seo: | ||
|title=Charak Samhita | |||
|titlemode=append | |||
|keywords= Curcuma longa L.,Haridra, haldi, Turmeric, Golden spice, cosmetics, Charak Samhita, Dravyaguna, carakasamhitaonline, carakasamhita, caraka samhita, Ayurveda, Charak Samhita English translation, ancient Ayurveda text, Indian system of medicine, Ayurveda, Charak, Charaka Samhita, agnivesha, atreya, gopal basisht, yogesh deole, charak samhita wikipedia edition, charak samhita new edition, charaka samhita new edition, carak samhita new edition, caraka samhita new edition, research on charak samhita, text book charak samhita, fundamental principles of ayurveda, basic concepts of ayurveda, | |||
|description= Haridra (Curcuma longa L.), widely known as turmeric, is a perennial rhizomatous herb of the family Zingiberaceae | |||
|image=http://www.carakasamhitaonline.com/resources/assets/ogimgs.jpg | |||
|image_alt=charak samhita | |||
|type=article | |||
}} | |||
[https://en.wikipedia.org/wiki/Turmeric Curcuma longa L.] | |||
{{Infobox | {{Infobox | ||
| Line 12: | Line 22: | ||
|data4 = Available | |data4 = Available | ||
|label5 = Contributors | |label5 = Contributors | ||
|data5 = | |data5 = Team Dravyaguna | ||
|label6 = Year of publication | |label6 = Year of publication | ||
|data6 = | |data6 = 2026 | ||
|label7 = Publisher | |label7 = Publisher | ||
|data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | |data7 = [[Charak Samhita Research, Training and Skill Development Centre]] | ||
| Line 21: | Line 31: | ||
}} | }} | ||
== | '''Haridra''' (''[[Curcuma longa]]'' L.), widely known as [[turmeric]], is a perennial rhizomatous herb of the family [[Zingiberaceae]]<ref name="Fuloria2022">{{cite journal |last1=Fuloria |first1=Shivkanya |last2=Mehta |first2=Jyoti |last3=Chandel |first3=Aditi |last4=Sekar |first4=Mahendran |last5=Rani |first5=Nur Najihah Izzati Mat |year=2022 |title=A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin |journal=Frontiers in Pharmacology |volume=13 |pages=820806 |doi=10.3389/fphar.2022.820806 |pmc=8990857}}</ref>. Celebrated in [[Ayurveda|Ayurvedic medicine]] for millennia as a potent ''Vishaghna'' (antitoxic), ''Kushthaghna'' (alleviator of skin diseases), and ''Pramehahara'' (antidiabetic) agent, modern pharmacological research has extensively validated its molecular mechanisms<ref name="Razavi2021">{{cite journal |last1=Razavi |first1=Bibi Marjan |last2=Ghasemzadeh Rahbardar |first2=Mahboobeh |last3=Hosseinzadeh |first3=Hossein |year=2021 |title=A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents |journal=Phytotherapy Research |volume=35 |issue=12 |pages=6489–6513 |doi=10.1002/ptr.7224 |pmid=34312922}}</ref>. Its therapeutic actions are primarily driven by polyphenolic [[curcuminoids]] and volatile [[sesquiterpenes]]<ref name="Hewlings2017">{{cite journal |last1=Hewlings |first1=Susan J. |last2=Kalman |first2=Douglas S. |year=2017 |title=Curcumin: A Review of Its Effects on Human Health |journal=Foods |volume=6 |issue=10 |pages=92 |doi=10.3390/foods6100092 |pmid=29065496 |pmc=5664031}}</ref>. | ||
== Classical Ayurvedic Pharmacodynamics == | |||
In Ayurvedic pharmacology, ''Haridra'' possesses balanced properties that make it effective for pacifying ''[[Kapha]]'' and ''[[Pitta]]'' [[Dosha|doshas]]. | |||
; [[Rasa (Ayurveda)|Rasa]] (Taste) : ''Tikta'' (Bitter), ''Katu'' (Pungent) | |||
; [[Guna (Ayurveda)|Guna]] (Qualities) : ''Ruksha'' (Dry), ''Laghu'' (Light) | |||
; [[Veerya]] (Potency) : ''Ushna'' (Heating) | |||
; [[Vipaka]] (Post-digestive effect) : ''Katu'' (Pungent) | |||
; Dosha Karma : ''Kapha-Pitta Shamaka'' (Pacifies Kapha and Pitta) | |||
; Therapeutic Actions (''Karma'') : | |||
==Therapeutic Uses== | ==Therapeutic Uses== | ||
| Line 47: | Line 65: | ||
Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati | Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati | ||
Academy, 2015;</ref> | Academy, 2015;</ref> | ||
# Haridra ( Curcuma longa) | # Haridra (Curcuma longa) | ||
# Amragandhi Haridra ( Curcuma amada) | # Amragandhi Haridra (Curcuma amada) | ||
# Vana Haridra ( Curcuma aromatica) | # Vana Haridra (Curcuma aromatica) | ||
# Daru Haridra ( Berberis aristata) | # Daru Haridra (Berberis aristata) | ||
* Dalhana | * Dalhana | ||
| Line 56: | Line 74: | ||
# Daru Haridra | # Daru Haridra | ||
== Synonyms in | == Synonyms in Bhavaprakasha Nighantu== | ||
Haridra, Kanchani, Pita, Nisha, Varavarnini, Krumighna, Haladi, Yoshitpriya, Hattavilasini<ref>Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 171 Edited by | Haridra, Kanchani, Pita, Nisha, Varavarnini, Krumighna, Haladi, Yoshitpriya, Hattavilasini<ref>Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 171 Edited by | ||
Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati | Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati | ||
| Line 80: | Line 95: | ||
| 4 || Qualities ([[guna]])|| Rough (ruksha), Light (laghu) | | 4 || Qualities ([[guna]])|| Rough (ruksha), Light (laghu) | ||
|- | |- | ||
| 5 || Actions ([[karma]]) || Pacify [[kapha]], [[vata]] and [[pitta]]. It also expels the [[pitta]] (pitta rechak) | | 5 || Actions ([[karma]]) || Pacify [[kapha]], [[vata]] and [[pitta]]. It also expels the [[pitta]] (pitta rechak),Varnya (Complexion enhancing), Krimighna (Antimicrobial/Antiparasitic), Pramehahara (Anti-diabetic), Lekhana (Scraping/Anti-lipidemic), Vrana Ropana(Wound healing). | ||
|- | |- | ||
|} | |} | ||
| Line 106: | Line 121: | ||
==Dose== | ==Dose== | ||
1-3 gm of the drug in powder form.<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30</ref> | 1-3 gm of the drug in powder form.<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30</ref> | ||
==Important Formulations== | ==Important Formulations== | ||
As per A.P.I.<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30</ref> | As per A.P.I.<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30</ref> | ||
* Haridra Khanda | * Haridra Khanda | ||
| Line 124: | Line 141: | ||
== Current researches == | == Current researches == | ||
[[Category: Database of herbs and minerals | Herbs]] | === Major Bioactive Compounds === | ||
The therapeutic efficacy of ''Curcuma longa'' is attributed to two primary chemical fractions<ref name="Fuloria2022"/>: | |||
{| class="wikitable" | |||
|+ Bioactive Fractions of ''Curcuma longa'' | |||
|- | |||
! Compound Category !! Major Constituents !! Biological Significance | |||
|- | |||
| '''[[Curcuminoid|Curcuminoids]]''' (~3–6%) || [[Curcumin]] (Curcumin I), Demethoxycurcumin (Curcumin II), Bisdemethoxycurcumin (Curcumin III) || Primary anti-inflammatory, antioxidant, neuroprotective, and antineoplastic agents. | |||
|- | |||
| '''Volatile Essential Oils''' (~3–7%) || [[Turmerone|α-turmerone]], β-turmerone, ar-turmerone, α-atlantone, xanthorrhizol || Antimicrobial, neurogenic, anti-fungal, and bioavailability-enhancing properties. | |||
|} | |||
== Pharmacological Mechanisms & Scientific Evidence == | |||
=== Anti-inflammatory & Immunomodulatory Efficacy === | |||
Curcumin acts as a multi-target anti-inflammatory agent. Unlike synthetic [[NSAID]]s that target specific enzymes, curcumin downregulates key inflammatory cascades<ref name="Hewlings2017"/>: | |||
* '''Inhibition of [[NF-κB]] Pathway:''' Suppresses nuclear factor kappa B (NF-κB) activation, inhibiting downstream pro-inflammatory cytokines such as [[Tumor necrosis factor alpha|TNF-α]], [[Interleukin 1 beta|IL-1β]], [[Interleukin 6|IL-6]], and [[Interleukin 8|IL-8]]<ref name="Razavi2021"/>. | |||
* '''Enzymatic Downregulation:''' Directly inhibits cyclooxygenase-2 ('''[[COX-2]]'''), 5-lipoxygenase ('''[[ALOX5|5-LOX]]'''), and inducible nitric oxide synthase ('''[[NOS2|iNOS]]''')<ref name="Hewlings2017"/>. | |||
Systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that turmeric extracts significantly reduce joint pain and stiffness in knee [[osteoarthritis]] patients with efficacy comparable to [[ibuprofen]], but with fewer gastrointestinal adverse events<ref name="Daily2016">{{cite journal |last1=Daily |first1=James W. |last2=Yang |first2=Mini |last3=Park |first3=Sunmin |year=2016 |title=Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials |journal=Journal of Medicinal Food |volume=19 |issue=8 |pages=717–729 |doi=10.1089/jmf.2016.3705 |pmid=27533649 |pmc=5003001}}</ref><ref name="Zeng2022">{{cite journal |last1=Zeng |first1=Liuting |last2=Yang |first2=Tiejun |last3=Yang |first3=Kailin |last4=Yu |first4=Ganpeng |last5=Li |first5=Jun |year=2022 |title=Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial |journal=Frontiers in Immunology |volume=13 |pages=891822 |doi=10.3389/fimmu.2022.891822 |pmc=9353077}}</ref>. | |||
=== Antioxidant & Cytoprotective Activity === | |||
Curcumin functions both as a direct free-radical scavenger and as an inducer of endogenous antioxidant defenses<ref name="Hewlings2017"/>: | |||
* Scavenges [[reactive oxygen species]] (ROS) and [[reactive nitrogen species]] (RNS). | |||
* Activates the '''[[NFE2L2|Nrf2]]-ARE pathway''', upregulating phase II detoxifying enzymes, including [[superoxide dismutase]] (SOD), [[catalase]] (CAT), [[glutathione peroxidase]] (GPx), and [[heme oxygenase-1]] (HO-1)<ref name="Hewlings2017"/>. | |||
=== Metabolic & Antidiabetic Actions === | |||
Aligning with its classical classification as a ''Pramehahara'' herb, ''Curcuma longa'' exhibits pronounced metabolic regulation<ref name="Fuloria2022"/>: | |||
* '''[[AMP-activated protein kinase|AMPK]] Activation:''' Activates AMPK, suppressing hepatic gluconeogenesis and enhancing glucose uptake in skeletal muscle. | |||
* '''Insulin Sensitivity:''' Improves insulin receptor phosphorylation and downregulates inflammatory markers in adipose tissue that drive [[insulin resistance]]. | |||
* '''Lipid Modulation:''' Lowers serum [[low-density lipoprotein]] (LDL) cholesterol and triglycerides while raising [[high-density lipoprotein]] (HDL) levels through [[Peroxisome proliferator-activated receptor gamma|PPAR-γ]] modulation<ref name="Hewlings2017"/>. | |||
=== Neuroprotective & Cognitive Efficacy === | |||
* '''[[Amyloid beta|Amyloid-β]] Aggregation Inhibition:''' Curcumin crosses the [[blood–brain barrier]], directly binding to and destabilizing amyloid-beta plaques in [[Alzheimer's disease]] models<ref name="Noorafshan2013">{{cite journal |last1=Noorafshan |first1=Ali |last2=Ashkani-Esfahani |first2=Soheil |year=2013 |title=A Review of Therapeutic Effects of Curcumin |journal=Current Pharmaceutical Design |volume=19 |issue=11 |pages=2032–2046 |doi=10.2174/1381612811319110006 |pmid=23116311}}</ref>. | |||
* '''Neurogenesis Promotion:''' ''ar-Turmerone'' has been shown to induce [[neural stem cell]] proliferation and differentiation. | |||
* '''BDNF Upregulation:''' Elevates [[Brain-derived neurotrophic factor|Brain-Derived Neurotrophic Factor]] (BDNF) levels, counteracting neurodegenerative processes and stress-induced cognitive decline<ref name="Noorafshan2013"/>. | |||
=== Wound Healing & Dermatological Applications === | |||
Traditional use as ''Vrana Ropana'' (wound healer) is validated by its ability to accelerate tissue repair<ref name="Fuloria2022"/>: | |||
* Enhances [[epithelialization]], increases [[collagen]] deposition, and speeds up tissue remodeling. | |||
* Exhibits broad-spectrum antibacterial activity against pathogens such as ''[[Staphylococcus aureus]]'' and ''[[Pseudomonas aeruginosa]]''. | |||
== Bioavailability & Pharmacokinetic Strategies == | |||
Despite high bioactivity ''in vitro'', native curcumin displays poor systemic [[bioavailability]] due to low aqueous solubility, poor intestinal absorption, and rapid hepatic metabolism (glucuronidation and sulfation)<ref name="Anand2007">{{cite journal |last1=Anand |first1=Preetha |last2=Kunnumakkara |first2=Ajaikumar B. |last3=Newman |first3=Robert A. |last4=Aggarwal |first4=Bharat B. |year=2007 |title=Bioavailability of curcumin: problems and promises |journal=Molecular Pharmaceutics |volume=4 |issue=6 |pages=807–818 |doi=10.1021/mp070113r |pmid=17999464}}</ref>. | |||
Modern delivery formulations overcome these barriers: | |||
* '''[[Piperine]] Synergy:''' Co-administration with piperine (from ''[[Piper nigrum]]'') increases bioavailability by '''2000%''' by inhibiting hepatic and intestinal glucuronidation<ref name="Anand2007"/>. | |||
* '''Liposomal & Nanoparticulate Curcumin:''' Enhances cellular uptake and extends plasma half-life<ref name="Anand2007"/>. | |||
* '''Phytosome Formulations:''' Complexing curcumin with phospholipids improves oral absorption significantly compared to unformulated extracts. | |||
== Safety, Toxicology & Contraindications == | |||
* '''[[Generally recognized as safe|GRAS]] Status:''' Curcumin is recognized as GRAS by the US [[FDA]]. Clinical trials confirm safety at oral doses up to '''8,000 to 12,000 mg/day'''<ref name="Hewlings2017"/><ref name="Anand2007"/>. | |||
* '''Adverse Effects:''' Mild gastrointestinal upset (nausea, diarrhea, dyspepsia) may occur at very high doses. | |||
* '''Contraindications:''' | |||
** '''[[Biliary tract|Biliary Obstruction]]:''' Contraindicated in acute bile duct obstruction or [[gallstone]]s due to its cholagogic effect (stimulation of gallbladder contraction). | |||
** '''Bleeding Disorders:''' May exert mild antiplatelet effects; exercise caution when combining with anticoagulant medications (e.g., [[Warfarin]], [[Aspirin]]). | |||
== References == | |||
{{reflist}} | |||
== External Links == | |||
[https://cb.imsc.res.in/imppat/phytochemical-detailedpage/IMPHY007574 IMPPAT database] | |||
[[Category:Database of herbs and minerals|Herbs]] | |||
Latest revision as of 04:54, 28 July 2026
| Section/Chapter | Herb database/Haridra |
|---|---|
| Botanical name(s) | Curcuma longa L. |
| Family | Zingiberaceae |
| Availability | Available |
| Contributors | Team Dravyaguna |
| Year of publication | 2026 |
| Publisher | Charak Samhita Research, Training and Skill Development Centre |
| DOI | Awaited |
Haridra (Curcuma longa L.), widely known as turmeric, is a perennial rhizomatous herb of the family Zingiberaceae[1]. Celebrated in Ayurvedic medicine for millennia as a potent Vishaghna (antitoxic), Kushthaghna (alleviator of skin diseases), and Pramehahara (antidiabetic) agent, modern pharmacological research has extensively validated its molecular mechanisms[2]. Its therapeutic actions are primarily driven by polyphenolic curcuminoids and volatile sesquiterpenes[3].
Classical Ayurvedic Pharmacodynamics
In Ayurvedic pharmacology, Haridra possesses balanced properties that make it effective for pacifying Kapha and Pitta doshas.
- Rasa (Taste)
- Tikta (Bitter), Katu (Pungent)
- Guna (Qualities)
- Ruksha (Dry), Laghu (Light)
- Veerya (Potency)
- Ushna (Heating)
- Vipaka (Post-digestive effect)
- Katu (Pungent)
- Dosha Karma
- Kapha-Pitta Shamaka (Pacifies Kapha and Pitta)
- Therapeutic Actions (Karma)
Therapeutic Uses
Pandu (Anaemia and diseases related to blood deficiency)), Prameha (Obstinate Urinary disorders including Diabetes mellitus), Vrana (Wound), Vishavikara (Poisons), Kushtha (Obstinate skin diseases), Tvakroga (Skin disorders), Shitapitta (Urticaria), Pinasa (Rhinorrhoea)[4]
Other Varieties / Botanical names
- Curcuma domestica Valeton
- Curcuma amada
- Curcuma aromatica
- Curcuma angustifolia
- Curcuma zedoria
Identification Characters
- Pita – Rhizome of Haridra is yellow and flowers are also yellow coloured.
- Kanchani – Haridra rhizome is yellow like that of Gold.
- Nishakhya – Turmeric is also known by names like Nisha, Rajani, etc., owing to its yellow-colored rhizome.
- Varavarnini – Haridra has an attractive bright yellow color.
Types
- Bhavaprakasha Nighantu
Mentioned 4 types[5]
- Haridra (Curcuma longa)
- Amragandhi Haridra (Curcuma amada)
- Vana Haridra (Curcuma aromatica)
- Daru Haridra (Berberis aristata)
- Dalhana
- Pinda Haridra
- Daru Haridra
Synonyms in Bhavaprakasha Nighantu
Haridra, Kanchani, Pita, Nisha, Varavarnini, Krumighna, Haladi, Yoshitpriya, Hattavilasini[6]
Ayurvedic pharmacological properties
| Sr.no. | Pharmacological criteria | Properties |
|---|---|---|
| 1 | Taste (rasa) | Bitter (tikta), Pungent (katu) |
| 2 | Potency (veerya) | Hot (ushna) |
| 3 | Post digestion effect (vipaka) | Pungent (katu) |
| 4 | Qualities (guna) | Rough (ruksha), Light (laghu) |
| 5 | Actions (karma) | Pacify kapha, vata and pitta. It also expels the pitta (pitta rechak),Varnya (Complexion enhancing), Krimighna (Antimicrobial/Antiparasitic), Pramehahara (Anti-diabetic), Lekhana (Scraping/Anti-lipidemic), Vrana Ropana(Wound healing). |
Reference in Charak Samhita and its actions
| Sr.no. | Reference in Charak Samhita | Activity |
|---|---|---|
| 1 | Cha.Sa.Sutra Sthana 2/5 | Sirovirechana (Errhine therapy) |
| 2 | Cha.Sa.Sutra Sthana 3/3 | Siddhatamachurnapradeha(paste) for local application |
| 3 | Cha.Sa.Sutra Sthana 4/9(3) | Lekhaniyamahakashaya(emaciating) |
| 4 | Cha.Sa.Sutra Sthana 4/9(13) | Kushthaghnamahakashay (anti – dermatosis) |
| 5 | Cha.Sa.Sutra Sthana 4/9(16) | Vishaghnamahakashay(anti- toxic) |
| 6 | Cha.Sa.Kalpa Sthana 7/16 | Preparations of Trivrut |
Dose
1-3 gm of the drug in powder form.[7]
Important Formulations
As per A.P.I.[8]
- Haridra Khanda
Current availability
Available
- India-
Andhra Pradesh, Tamil Nadu, Orissa, Karnataka, West Bengal, Gujarat, Meghalaya, Maharashtra and Assam.
- Out of India-
Asian countries (Pakistan, Malaysia, Myanmar, Vietnam, Thailand, Philipines, Japan, Korea & China) Bangladesh, Cambodia, Indonesia, Peru, Madagascar, Australia, Africa, Taiwan, Haiti, Jamaica, Sri Lanka and West Indies
Current researches
Major Bioactive Compounds
The therapeutic efficacy of Curcuma longa is attributed to two primary chemical fractions[1]:
| Compound Category | Major Constituents | Biological Significance |
|---|---|---|
| Curcuminoids (~3–6%) | Curcumin (Curcumin I), Demethoxycurcumin (Curcumin II), Bisdemethoxycurcumin (Curcumin III) | Primary anti-inflammatory, antioxidant, neuroprotective, and antineoplastic agents. |
| Volatile Essential Oils (~3–7%) | α-turmerone, β-turmerone, ar-turmerone, α-atlantone, xanthorrhizol | Antimicrobial, neurogenic, anti-fungal, and bioavailability-enhancing properties. |
Pharmacological Mechanisms & Scientific Evidence
Anti-inflammatory & Immunomodulatory Efficacy
Curcumin acts as a multi-target anti-inflammatory agent. Unlike synthetic NSAIDs that target specific enzymes, curcumin downregulates key inflammatory cascades[3]:
- Inhibition of NF-κB Pathway: Suppresses nuclear factor kappa B (NF-κB) activation, inhibiting downstream pro-inflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-8[2].
- Enzymatic Downregulation: Directly inhibits cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and inducible nitric oxide synthase (iNOS)[3].
Systematic reviews and meta-analyses of randomized controlled trials (RCTs) confirm that turmeric extracts significantly reduce joint pain and stiffness in knee osteoarthritis patients with efficacy comparable to ibuprofen, but with fewer gastrointestinal adverse events[9][10].
Antioxidant & Cytoprotective Activity
Curcumin functions both as a direct free-radical scavenger and as an inducer of endogenous antioxidant defenses[3]:
- Scavenges reactive oxygen species (ROS) and reactive nitrogen species (RNS).
- Activates the Nrf2-ARE pathway, upregulating phase II detoxifying enzymes, including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and heme oxygenase-1 (HO-1)[3].
Metabolic & Antidiabetic Actions
Aligning with its classical classification as a Pramehahara herb, Curcuma longa exhibits pronounced metabolic regulation[1]:
- AMPK Activation: Activates AMPK, suppressing hepatic gluconeogenesis and enhancing glucose uptake in skeletal muscle.
- Insulin Sensitivity: Improves insulin receptor phosphorylation and downregulates inflammatory markers in adipose tissue that drive insulin resistance.
- Lipid Modulation: Lowers serum low-density lipoprotein (LDL) cholesterol and triglycerides while raising high-density lipoprotein (HDL) levels through PPAR-γ modulation[3].
Neuroprotective & Cognitive Efficacy
- Amyloid-β Aggregation Inhibition: Curcumin crosses the blood–brain barrier, directly binding to and destabilizing amyloid-beta plaques in Alzheimer's disease models[11].
- Neurogenesis Promotion: ar-Turmerone has been shown to induce neural stem cell proliferation and differentiation.
- BDNF Upregulation: Elevates Brain-Derived Neurotrophic Factor (BDNF) levels, counteracting neurodegenerative processes and stress-induced cognitive decline[11].
Wound Healing & Dermatological Applications
Traditional use as Vrana Ropana (wound healer) is validated by its ability to accelerate tissue repair[1]:
- Enhances epithelialization, increases collagen deposition, and speeds up tissue remodeling.
- Exhibits broad-spectrum antibacterial activity against pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa.
Bioavailability & Pharmacokinetic Strategies
Despite high bioactivity in vitro, native curcumin displays poor systemic bioavailability due to low aqueous solubility, poor intestinal absorption, and rapid hepatic metabolism (glucuronidation and sulfation)[12].
Modern delivery formulations overcome these barriers:
- Piperine Synergy: Co-administration with piperine (from Piper nigrum) increases bioavailability by 2000% by inhibiting hepatic and intestinal glucuronidation[12].
- Liposomal & Nanoparticulate Curcumin: Enhances cellular uptake and extends plasma half-life[12].
- Phytosome Formulations: Complexing curcumin with phospholipids improves oral absorption significantly compared to unformulated extracts.
Safety, Toxicology & Contraindications
- GRAS Status: Curcumin is recognized as GRAS by the US FDA. Clinical trials confirm safety at oral doses up to 8,000 to 12,000 mg/day[3][12].
- Adverse Effects: Mild gastrointestinal upset (nausea, diarrhea, dyspepsia) may occur at very high doses.
- Contraindications:
- Biliary Obstruction: Contraindicated in acute bile duct obstruction or gallstones due to its cholagogic effect (stimulation of gallbladder contraction).
- Bleeding Disorders: May exert mild antiplatelet effects; exercise caution when combining with anticoagulant medications (e.g., Warfarin, Aspirin).
References
- ↑ 1.0 1.1 1.2 1.3 Fuloria, Shivkanya; Mehta, Jyoti; Chandel, Aditi; Sekar, Mahendran; Rani, Nur Najihah Izzati Mat (2022). "A Comprehensive Review on the Therapeutic Potential of Curcuma longa Linn. in Relation to its Major Active Constituent Curcumin". Frontiers in Pharmacology. 13: 820806. PMC 8990857
Check |pmc=value (help). doi:10.3389/fphar.2022.820806. - ↑ 2.0 2.1 Razavi, Bibi Marjan; Ghasemzadeh Rahbardar, Mahboobeh; Hosseinzadeh, Hossein (2021). "A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents". Phytotherapy Research. 35 (12): 6489–6513. PMID 34312922 Check
|pmid=value (help). doi:10.1002/ptr.7224. - ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 Hewlings, Susan J.; Kalman, Douglas S. (2017). "Curcumin: A Review of Its Effects on Human Health". Foods. 6 (10): 92. PMC 5664031 . PMID 29065496. doi:10.3390/foods6100092.
- ↑ Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30
- ↑ Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 171 Edited by Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati Academy, 2015;
- ↑ Shri Bhavamishra, Bhavaprakash Nighantu, Haritakyadi Varga, Verse no. 171 Edited by Padmashree Pro. Krushnachandra Chunekar, Reprint Edition, Chaukhambha Bharati Academy, 2015;
- ↑ Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30
- ↑ Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:30
- ↑ Daily, James W.; Yang, Mini; Park, Sunmin (2016). "Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials". Journal of Medicinal Food. 19 (8): 717–729. PMC 5003001 . PMID 27533649. doi:10.1089/jmf.2016.3705.
- ↑ Zeng, Liuting; Yang, Tiejun; Yang, Kailin; Yu, Ganpeng; Li, Jun (2022). "Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial". Frontiers in Immunology. 13: 891822. PMC 9353077 Check
|pmc=value (help). doi:10.3389/fimmu.2022.891822. - ↑ 11.0 11.1 Noorafshan, Ali; Ashkani-Esfahani, Soheil (2013). "A Review of Therapeutic Effects of Curcumin". Current Pharmaceutical Design. 19 (11): 2032–2046. PMID 23116311. doi:10.2174/1381612811319110006.
- ↑ 12.0 12.1 12.2 12.3 Anand, Preetha; Kunnumakkara, Ajaikumar B.; Newman, Robert A.; Aggarwal, Bharat B. (2007). "Bioavailability of curcumin: problems and promises". Molecular Pharmaceutics. 4 (6): 807–818. PMID 17999464. doi:10.1021/mp070113r.